CalY is a major virulence factor and a biofilm matrix protein

Thomas Candela1, Annette Fagerlund2, Christophe Buisson1

  • 1Micalis Institute, INRA, AgroParisTech, Université Paris-Saclay, Jouy-en-Josas, 78350, France.

Molecular Microbiology
|December 15, 2018
PubMed

Insights

Bacillus thuringiensis CalY protein acts as a cell-surface adhesin in early growth and forms extracellular amyloid fibers in biofilms. This bifunctional protein is crucial for bacterial adhesion and virulence.

Area of Science:

  • Microbiology
  • Structural Biology
  • Biochemistry

Background:

  • Extracellular biofilm matrices often contain amyloid fibers.
  • In Bacillus cereus, TasA and CalY proteins form these amyloid fibers.
  • The function of CalY in Bacillus thuringiensis is not fully understood.

Purpose of the Study:

  • To investigate the dual function of CalY in Bacillus thuringiensis.
  • To determine the role of CalY in bacterial adhesion and biofilm formation.
  • To elucidate the mechanism behind CalY's localization shift.

Main Methods:

  • Immunodetection to locate CalY.
  • Gene deletion studies (calY, sipW) to assess protein function.
  • Adhesion assays with HeLa cells and Galleria mellonella hemocytes.
  • Virulence assays in insect larvae.
  • Analysis of protein polymerization in vitro.

Main Results:

  • CalY is located on the bacterial cell surface in early stationary phase.
  • CalY deletion significantly reduces adhesion to host cells and virulence.
  • CalY shifts to the extracellular medium in mid-stationary phase and biofilms, forming fibers.
  • SipW signal peptidase activity influences CalY localization.
  • CalY polymerization requires cell-surface components.

Conclusions:

  • CalY is a bifunctional protein in Bacillus thuringiensis.
  • CalY functions as a cell-surface adhesin early in growth.
  • CalY contributes to biofilm structure by forming extracellular fibers later in growth.
  • CalY's localization and function are regulated by SipW and cell-surface interactions.

Related Concept Videos

Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
558
Collagens are the Major Structural Proteins of ECM01:13

Collagens are the Major Structural Proteins of ECM

Three main types of fibers are secreted by fibroblasts: collagen fibers, elastic fibers, and reticular fibers. Collagen fiber is made from fibrous protein subunits linked together to form a long, straight fiber. Collagen fibers, while flexible, have great tensile strength, resist stretching, and give ligaments and tendons their characteristic resilience and strength. These fibers hold connective tissues together, even during the body's movement.
Connective tissue proper includes loose...
5.8K
Golgi Matrix Proteins01:12

Golgi Matrix Proteins

Golgi matrix proteins are a group of highly dynamic proteins that maintain the stacked structure of Golgi. These proteins adapt to rapid morphological changes of the Golgi during the cell cycle. During cell division, mild proteolysis removes these connections resulting in Golgi unstacking. In The daughter cells, these proteins help reassemble the unstacked Golgi.
One of the first identified Golgi matrix proteins was GM130, a rod-like protein located in the cis-Golgi. Subsequently, many Golgi...
2.5K
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
484
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
323
The Extracellular Matrix01:42

The Extracellular Matrix

Overview
89.0K